Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate.
Perez-Simón JA, Martino R, Parody R, Cabrero M, Lopez-Corral L, Valcarcel D, Martinez C, Solano C, Vazquez L, Márquez-Malaver FJ, Sierra J, Caballero D. Perez-Simón JA, et al. Among authors: cabrero m. Haematologica. 2013 Apr;98(4):526-32. doi: 10.3324/haematol.2012.065599. Epub 2012 Oct 12. Haematologica. 2013. PMID: 23065527 Free PMC article. Clinical Trial.
Late differentiation syndrome in acute promyelocytic leukemia: a challenging diagnosis.
Cabral R, Caballero JC, Alonso S, Dávila J, Cabrero M, Caballero D, Vázquez L, Sánchez-Guijo F, López L, Cañizo MC, Mateos MV, González M. Cabral R, et al. Among authors: cabrero m. Hematol Rep. 2014 Nov 19;6(4):5654. doi: 10.4081/hr.2014.5654. eCollection 2014 Nov 19. Hematol Rep. 2014. PMID: 25568763 Free PMC article.
Acute graft-versus-host disease and bronchiolitis obliterans after autologous stem cell transplantation in a patient with multiple myeloma.
Alonso S, Cabrero M, Caballero JC, Dávila J, de la Calle VG, López-Godino O, López-Corral L, Pérez E, Vázquez L, Corral R, Caballero D, Del Cañizo C, Mateos MV. Alonso S, et al. Among authors: cabrero m. Clin Case Rep. 2015 Jun;3(6):370-5. doi: 10.1002/ccr3.231. Epub 2015 Apr 9. Clin Case Rep. 2015. PMID: 26185631 Free PMC article.
Toxicity and efficacy of busulfan and fludarabine myeloablative conditioning for HLA-identical sibling allogeneic hematopoietic cell transplantation in AML and MDS.
De La Serna J, Sanz J, Bermúdez A, Cabrero M, Serrano D, Vallejo C, Gómez V, Moraleda JM, Perez SG, Caballero MD, Conde E, Lahuerta JJ, Sanz G. De La Serna J, et al. Among authors: cabrero m. Bone Marrow Transplant. 2016 Jul;51(7):961-6. doi: 10.1038/bmt.2016.42. Epub 2016 Mar 7. Bone Marrow Transplant. 2016. PMID: 26950372 Clinical Trial.
The addition of ofatumumab to the conditioning regimen does not improve the outcome of patients with high-risk CLL undergoing reduced intensity allogeneic haematopoietic cell transplantation: a pilot trial from the GETH and GELLC (CLL4 trial).
Montesinos P, Cabrero M, Valcárcel D, Rovira M, García-Marco JA, Loscertales J, Moreno C, Duarte R, Terol MJ, Villamor N, Abrisqueta P, Caballero D, Sanz J, Delgado J. Montesinos P, et al. Among authors: cabrero m. Bone Marrow Transplant. 2016 Oct;51(10):1404-1407. doi: 10.1038/bmt.2016.145. Epub 2016 May 23. Bone Marrow Transplant. 2016. PMID: 27214073 Clinical Trial. No abstract available.
Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.
Kekre N, Marquez-Malaver FJ, Cabrero M, Piñana J, Esquirol A, Soiffer RJ, Caballero D, Terol MJ, Martino R, Antin JH, Lopez-Corral L, Solano C, Armand P, Pérez-Simon JA. Kekre N, et al. Among authors: cabrero m. Biol Blood Marrow Transplant. 2016 Oct;22(10):1808-1815. doi: 10.1016/j.bbmt.2016.07.006. Epub 2016 Jul 25. Biol Blood Marrow Transplant. 2016. PMID: 27470290 Free article.
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial.
Cabrero M, Martin A, Briones J, Gayoso J, Jarque I, López J, Grande C, Heras I, Arranz R, Bernal T, Perez-Lopez E, López-Godino O, Conde E, Caballero D. Cabrero M, et al. Biol Blood Marrow Transplant. 2017 Jan;23(1):53-59. doi: 10.1016/j.bbmt.2016.10.003. Epub 2016 Oct 19. Biol Blood Marrow Transplant. 2017. PMID: 27771496 Free article. Clinical Trial.
18F-FDG PET/CT in the clinical management of patients with lymphoma.
Tamayo P, Martín A, Díaz L, Cabrero M, García R, García-Talavera P, Caballero D. Tamayo P, et al. Among authors: cabrero m. Rev Esp Med Nucl Imagen Mol. 2017 Sep-Oct;36(5):312-321. doi: 10.1016/j.remn.2017.03.004. Epub 2017 May 5. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28483374 Review. English, Spanish.
38 results